A phase II randomized study of vinorelbine alone or with cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly

Lung Cancer

Volumn 61, Issue 2, 2008, Pages 214-219

  Chen, Yuh Min ^a,b   Perng, Reury Perng ^a   Shih, Jen Fu ^a   Whang Peng, Jacqueline ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Cisplatin; Elderly; Non small cell lung cancer; Vinorelbine

Indexed keywords

CISPLATIN; DEXAMETHASONE; GRANISETRON; METOCLOPRAMIDE; NAVELBINE;

AGED; ANEMIA; ANOREXIA; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DRUG INFUSION; DRUG SAFETY; DYSPNEA; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FATIGUE; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; FEMALE; FLUID THERAPY; HEMOPTYSIS; HUMAN; INTERMETHOD COMPARISON; KIDNEY FUNCTION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PAIN; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DRUG TOXICITY; FATIGUE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEUTROPENIA; SURVIVAL ANALYSIS; VINBLASTINE;

EID: 47649090643     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.12.009     Document Type: Article

References (18)

1. Schottenfeld D. Etiology and epidemiology of lung cancer. In: Pass H.I., Mitchell J.B., Johnson D.H., et al. (Eds). Lung cancer-principles and practice (2000), Lippincott Williams & Wilkins, Philadelphia 367-388
2. Lee-Chiong Jr. T.L., and Matthay R.A. Lung cancer in the elderly patient. Clin Chest Med 14 (1993) 453-478
3. Kuo C.W., Chen Y.M., Chao J.Y., Tsai C.M., and Perng R.P. Non-small cell lung cancer in very young and very old patients. Chest 117 (2000) 354-357
4. Chen Y.M., Perng R.P., Shih J.F., Tsai C.M., and Whang-Peng J. Chemotherapy for non-small-cell lung cancer in elderly patients. Chest 128 (2005) 132-139
5. Langer C.J., Manola J., Bernardo P., Kugler J.W., Bonomi P., Cella D., et al. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst 94 (2002) 173-181
6. Bunn Jr. P.A., and Kelly K. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions. Clin Cancer Res 4 (1998) 1087-1100
7. Pfister D.G., Johnson D.H., Azzoli C.G., Sause W., Smith T.J., Baker Jr. S., et al. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol 22 (2004) 330-353
8. The elderly lung cancer vinorelbine Italian study group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 91 (1999) 66-72
9. Gridelli C., Perrone F., Gallo C., Cigolari S., Rossi A., Piantedosi F., et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the multicenter Italian lung cancer in the elderly study (MILES) phase III randomized trial. J Natl Cancer Inst 95 (2003) 362-372
10. Chen Y.M., Perng R.P., Shih J.F., Lee Y.C., Lee C.S., Tsai C.M., et al. A randomized phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated. Br J Cancer 90 (2004) 359-365
11. Hollen P.J., and Gralla R.J. Comparison of instruments for measuring quality of life in patients with lung cancer. Semin Oncol 23 Suppl. 5 (1996) 31-40
12. Simon R., Wittes R.E., and Ellenberg S.S. Randomized phase II clinical trials. Cancer Treat Rep 69 (1985) 1375-1381
13. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 (2000) 205-216
14. Rossi A., and Gridelli C. Chemotherapy of advanced non-small cell lung cancer in elderly patients. Ann Oncol 17 Suppl. 2 (2006) ii58-ii60
15. Gridelli C., Langer C., Maione P., Rossi A., and Schild S.E. Lung cancer in the elderly. J Clin Oncol 25 (2007) 1898-1907
16. Chen Y.M., Perng R.P., Tsai C.M., and Whang-Peng J. A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naïve inoperable non-small cell lung cancer in the elderly. J Thor Oncol 1 (2006) 141-145
17. Shepherd F.A., Pereira J.R., Ciuleanu T., Tan E.H., Hirsh V., Thongprasert S., et al. Erlotinib in previously treated non-small-cell lung cancer. New Engl J Med 353 (2005) 123-132
18. Jackman D.M., Yeap B.Y., Lindeman N.I., Fidias P., Rabin M.S., Temel J., et al. Phase II clinical trial of chemotherapy-naïve patients ≥70 years of age treated with erlotinib for advanced non-small-cell lung cancer. J Clin Oncol 25 (2007) 760-766